GRI

GRI Bio, Inc. GRI

GRI
GRI Bio, Inc. CNSP
CNS Pharmaceuticals, Inc. JAGX
Jaguar Health, Inc. SILO
Silo Pharma, Inc. BDRX
Biodexa Pharmaceuticals Plc ABP
Abpro Corporation INM
InMed Pharmaceuticals Inc. CANF
Can-Fite BioPharma Ltd. SXTP
60 Degrees Pharmaceuticals, Inc. GNPX
Genprex, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode GRI CNSP JAGX SILO BDRX ABP INM CANF SXTP GNPX
6M -73.13 % -29.75 % -58.52 % -34.62 % -64.78 % -33.89 % -46.94 % -77.15 % -65.07 % -83.54 %
YTD -97.56 % -90.88 % -95.89 % -58.47 % -92.08 % -90.06 % -72.92 % -86.60 % -88.53 % -95.82 %
1Y -97.25 % -90.21 % -95.41 % -55.34 % -91.52 % -93.19 % -72.22 % -83.57 % -87.05 % -95.96 %
3Y -100.00 % -99.99 % -99.97 % -86.85 % -99.99 % -97.30 % -95.08 % -96.25 % -99.73 % -99.91 %
5Y -100.00 % -100.00 % -100.00 % 12.71 % -100.00 % -97.30 % -99.92 % -98.70 % -99.73 % -99.98 %
10Y -100.00 % -100.00 % -100.00 % 12.71 % -100.00 % -97.30 % -99.93 % -99.95 % -99.73 % -99.98 %
Depuis le début -100.00 % -100.00 % -100.00 % 12.71 % -100.00 % -97.30 % -99.97 % -99.97 % -99.73 % -99.98 %

Dividende